British Journal of Haematology, 0007-1048

Journal

1 - 10 out of 136Page size: 10

Publications

  1. 2020
  2. E-pub ahead of print

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).

    Sylvie Freeman, Oct 2020, In : British Journal of Haematology.

    Research output: Contribution to journal › Article

  3. E-pub ahead of print

    Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion

    & 8 others, , 14 Sep 2020, In : British Journal of Haematology.

    Research output: Contribution to journal › Article

  4. E-pub ahead of print

    Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)

    Sarah Pirrie, Eszter Nagy, Keith Wheatley, 14 Sep 2020, In : British Journal of Haematology.

    Research output: Contribution to journal › Article

  5. Accepted/In press

    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation

    Mark Kilby, 14 Aug 2020, (Accepted/In press) In : British Journal of Haematology.

    Research output: Contribution to journal › Article

  6. E-pub ahead of print

    Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting

    Sylvie Freeman & 4 others, , 2 Apr 2020, In : British Journal of Haematology.

    Research output: Contribution to journal › Article

  7. 2019
  8. Published

    The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience

    Justin Loke, Ram Malladi, Paul Moss & Charles Craddock, 21 Dec 2019, In : British Journal of Haematology. 188, 1, p. 129-146 18 p.

    Research output: Contribution to journal › Review article

  9. E-pub ahead of print

    A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)

    Yongzhong Sun, Andrea Roalfe, Pollyanna Hardy & David Fitzmaurice, 12 Nov 2019, In : British Journal of Haematology. 14 p.

    Research output: Contribution to journal › Article

  10. Published

    Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

    Pamela Kearns, 1 Aug 2019, In : British Journal of Haematology. 186, 3, p. e7-e11 4 p.

    Research output: Contribution to journal › Letter

  11. Published

    The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

    Dickens Pratt & Mark Drayson, May 2019, In : British Journal of Haematology. 185, 3, p. 450-467 18 p.

    Research output: Contribution to journal › Article

  12. Published

    A rare complication of bone marrow aspiration and trephine biopsy: staphylococcus aureus osteomyelitis and septicaemia

    Paul Moss, 1 Jan 2019, In : British Journal of Haematology. 184, 1, p. 7 1 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...14 Next